Skip to main content
Equibles

PRN · Profound Medical Corp.

Use PRN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PRN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
10.1400 CAD +0.5000 (+5.19%) At close · Nov 6 Intraday price with Plus
Rebalance outlook locked

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close10.1400 CAD Open9.6000 CAD Day8.6000–10.1900 CAD 52W close6.9900–12.1100 CAD Avg vol 30d17K Last earningsNov 5, 2026 DataJan 2020–Nov 2026

Latest documents

2026
Nov 5
Earnings call
Revenue rose 86%; Cook Medical agreement expands Tulsa sales

Profound reported third-quarter revenue of $9.8 million, up 86%, and projects full-year 2026 revenue of at least $25 million. The Tulsa Pro install base reached 98 systems, and a distribution agreement with Cook Medical was signed last week.

4 source passages
For the three-month ended September 30, 2026, Profound recorded total revenue of $9.8 million, up 86% from the third quarter of 2025. we are projecting our full 2026 revenue to be at least $25 million At the end of the third quarter, our Tulsa Pro install base was 98 systems. As Rich mentioned, we added a key new distribution channel for Tulsa products under a supply and distribution agreement signed last week with Cook Medical, one of the largest privately held medical device manufacturers in the United States. Open the document at this passage
Nov 5
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Quarterly report for FY2026 Q3 AI summary on its way
Revenue $9.83M ▲ 85.9% Net loss $7.72M Diluted EPS -$0.21
All documents

Quarterly results

Revenue Net income Net loss
· $4.18M −$4.95M '24 Q4* ▲82.1% $2.62M −$10.72M '25 Q1 ▼1% $2.21M −$15.70M '25 Q2 ▲86.8% $5.29M −$7.98M '25 Q3 ▲43.1% $5.98M −$8.17M '25 Q4* ▲103.6% $5.34M −$7.05M '26 Q1 ▲12.3% $2.48M −$9.54M '26 Q2 LATEST ▲85.9% $9.83M −$7.72M '26 Q3

* Q4 derived as the full year minus Q1 to Q3.

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 6.9900 CAD Now 10.1400 CAD · 62% Range high 12.1100 CAD
vs 200-day avg +10% vs 50-day avg +16%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XTSE:PRN +10.5% +3.1% +3.3% +10.5% -5.9%

Exchange listing

Market
XTSE
Ticker
PRN
ISIN
—
Security
Ordinary share
Trading currency
CAD

Company with tickers: PROF

Company

Website
https://www.profoundmedical.com/
Investor relations
https://ir.profoundmedical.com/

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Latest price

Plus & Pro

Follow PRN during the session: the latest price, the day's change, range and volume. Closing prices stay free.

View plans Sign in

Recent dividends

No verified dividend payments are available for this listing yet.

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q3 2026 2026-11-05 Audio Transcript
    Profound Medical Corp. Q3 FY2026 Earnings Call
  • Earnings call · Q2 2026 2026-08-06 Audio Transcript
    Earnings conference call (announced in 8-K)
  • Earnings call · Q1 2026 2026-05-07
    Profound Medical Corp. Q1 FY2026 Earnings Call
  • Earnings call · Q4 2025 2026-03-05 Transcript
    Profound Medical Corp. Q4 FY2025 Earnings Call
  • Earnings call · Q3 2025 2025-10-07 Transcript
    Profound Medical Corp. Q3 FY2025 Earnings Call
  • Earnings call · Q2 2025 2025-08-14 Transcript
    Profound Medical Corp. Q2 FY2025 Earnings Call
  • Earnings call · Q1 2025 2025-05-08 Transcript
    Profound Medical Corp. Q1 FY2025 Earnings Call
  • Capital Markets Day · April 2025 2025-04-28 Audio Transcript
    Analyst Day 2025
  • Earnings call · Q4 2024 2025-03-07 Transcript
    Profound Medical Corp. Q4 FY2024 Earnings Call
  • Earnings call · Q3 2024 2024-09-30 Transcript
    Profound Medical Corp. Q3 FY2024 Earnings Call